Gordon H. Copland
Steptoe & Johnson LLPGeneral
Experience24 yrs
Elite Ratings
--
Practice Areas
Chemical Biotech (5 cases)
Biotech (88 cases)
Chemical (3 cases)
Comp. Arch. and Software (4 cases)
Software, Security (2 cases)
Ratings
Experience
Grade
Trend
DCT
L3
D
PTAB
--
--
--
CAFC
--
--
--
Cases
Case # | Court | Caption | Filed | Represent |
|---|---|---|---|---|
| 1:24-CV-00082 | Boehringer Ingelheim Pharma Inc v. Mylan Pharma Inc | 08/29/24 | Challenger | |
| 1:24-MD-03103 | In Re: Aflibercept Patent Litigation | 04/11/24 | ||
| 1:24-CV-00036 | Bausch Health Ireland Ltd v. Mylan Pharma Inc | 04/05/24 | Challenger | |
| 1:23-CV-00088 | Actelion Pharma Ltd v. Mylan Pharma Inc | 11/07/23 | Challenger | |
| 1:23-CV-00033 | Abraxis Bioscience LLC v. Mylan Pharma Inc | 04/06/23 | ||
| 1:22-CV-00089 | Otsuka Pharmaceutical Co Ltd v. Mylan Laboratories Ltd | 09/09/22 | Challenger | |
| 1:22-CV-01040 | Novo Nordisk Inc v. Mylan Pharma Inc | 08/08/22 | ||
| 1:22-CV-00063 | Bayer Pharma AG v. Mylan Pharma Inc | 08/05/22 | Challenger : Mylan NV | |
| 1:22-CV-00061 | Regeneron Pharma Inc v. Mylan Pharma Inc | 08/02/22 | ||
| 1:22-CV-00035 | AstraZeneca Ab v. Mylan Pharma Inc | 04/26/22 |